The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b

Bone

Volumn 53, Issue 1, 2013, Pages 6-12

  Brun, Julia ^a,b   Fromigué, Olivia ^a,b   Dieudonné, François Xavier ^a,b   Marty, Caroline ^a,b   Chen, Ju ^c   Dahan, Jennifer ^d   Wei, Yu ^d   Marie, Pierre J ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d INSTITUT PASTEUR   (France)

Author keywords

Bone formation; FHL2; Osteoblast; Wnt signaling

Indexed keywords

BETA CATENIN; CELL PROTEIN; FHL2 PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; WNT10B PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MASS; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; GENE EXPRESSION; HISTOPATHOLOGY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENE SILENCING; LIM-HOMEODOMAIN PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MUSCLE PROTEINS; OSTEOBLASTS; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84871366321     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.11.020     Document Type: Article

References (39)

1. Westendorf J.J., Kahler R.A., Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
2. Bodine P.V., Komm B.S. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:33-39.
3. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling. J Clin Invest 2006, 116:1202-1209.
4. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
5. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005, 280:33132-33140.
6. Bodine P.V. Wnt signaling control of bone cell apoptosis. Cell Res 2008, 18:248-253.
7. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005, 102:3324-3329.
8. Bennett C.N., Ouyang H., Ma Y.L., Zeng Q., Gerin I., Sousa K.M., et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 2007, 22:1924-1932.
9. Bilkovski R., Schulte D.M., Oberhauser F., Gomolka M., Udelhoven M., Hettich M.M., et al. Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes. J Biol Chem 2010, 285:6170-6178.
10. Takada I., Kouzmenko A.P., Kato S. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 2009, 5:442-447.
11. Johannessen M., Moller S., Hansen T., Moens U., Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 2006, 63:268-284.
12. Kleiber K., Strebhardt K., Martin B.T. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target. Anticancer Res 2007, 27:55-61.
13. Martin B., Schneider R., Janetzky S., Waibler Z., Pandur P., Kuhl M., et al. The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J Cell Biol 2002, 159:113-122.
14. Wei Y., Renard C.A., Labalette C., Wu Y., Levy L., Neuveut C., et al. Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem 2003, 278:5188-5194.
15. Labalette C., Renard C.A., Neuveut C., Buendia M.A., Wei Y. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin. Mol Cell Biol 2004, 24:10689-10702.
16. Govoni K.E., Baylink D.J., Chen J., Mohan S. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice. Calcif Tissue Int 2006, 79:112-117.
17. Gunther T., Poli C., Muller J.M., Catala-Lehnen P., Schinke T., Yin N., et al. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J 2005, 24:3049-3056.
18. Hamidouche Z., Hay E., Vaudin P., Charbord P., Schüle R., Marie P.J., et al. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J 2008, 22:3813-3822.
19. Hä E., Laplantine E., Geoffroy V., Frain M., Kohler T., Müller R., et al. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation. Mol Cell Biol 2009, 29:953-964.
20. Miraoui H., Oudina K., Petite H., Tanimoto Y., Moriyama K., Marie P.J. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem 2009, 284:4897-4904.
21. Fromigué O., Hä E., Modrowski D., Bouvet S., Jacquel A., Auberger P., et al. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ 2006, 13:1845-1856.
22. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
23. Nusse R. Wnt signaling in disease and in development. Cell Res 2005, 15:28-32.
24. Kang S., Bennett C.N., Gerin I., Rapp L.A., Hankenson K.D., Macdougald O.A. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007, 282:14515-14524.
25. Harp J.B. New insights into inhibitors of adipogenesis. Curr Opin Lipidol 2004, 15:303-307.
26. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003, 4:119-129.
27. Teixeira C.C., Liu Y., Thant L.M., Pang J., Palmer G., Alikhani M. Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis. J Biol Chem 2010, 285:31055-31065.
28. Siqueira M.F., Flowers S., Bhattacharya R., Faibish D., Behl Y., Kotton D.N., et al. FOXO1 modulates osteoblast differentiation. Bone 2011, 48:1043-1051.
29. Yang Y., Hou H., Haller E.M., Nicosia S.V., Bai W. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J 2005, 24:1021-1032.
30. Amaar Y.G., Thompson G.R., Linkhart T.A., Chen S.T., Baylink D.J., Mohan S. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 2002, 277:12053-12060.
31. Govoni K.E., Amaar Y.G., Kramer A., Winter E., Baylink D.J., Mohan S. Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Growth Horm IGF Res 2006, 16:49-56.
32. Wixler V., Geerts D., Laplantine E., Westhoff D., Smyth N., Aumailley M., et al. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. J Biol Chem 2000, 275:33669-33678.
33. Gabriel B., Mildenberger S., Weisser C.W., Metzger E., Gitsch G., Schule R., et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res 2004, 24:921-927.
34. Muller J.M., Isele U., Metzger E., Rempel A., Moser M., Pscherer A., et al. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J 2000, 19:359-369.
35. Labalette C., Nouet Y., Sobczak-Thepot J., Armengol C., Levillayer F., Gendron M.C., et al. The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. J Biol Chem 2008, 283:15201-15208.
36. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953.
37. Jing E., Gesta S., Kahn C.R. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab 2007, 6:105-114.
38. Fan W., Imamura T., Sonoda N., Sears D.D., Patsouris D., Kim J.J., et al. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem 2009, 284:12188-12197.
39. Wang F., Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol Biol Cell 2009, 20:801-808.